AbbVie has claimed FDA approval for Emblaveo, a new antibiotic product to treat complicated intra-abdominal infections (cIAI), including those caused by Gram-negative bacteria that represent a ...

An antibiotic used to treat infective diarrhea could be an effective drug for a type of inflammatory bowel disease, a new study has found. This study, conducted by researchers from the University ...

Further BVA research shows that three out of five vets have seen clients who expect antibiotics to treat their pets and found there is still a lack of understanding about responsible antibiotic use ...

The FDA has approved AbbVie’s Emblaveo (aztreonam and avibactam), a fixed-dose, intravenous antibiotic to treat patients with complicated intra-abdominal infections (cIAI), which are a common cause of ...

In short: The Food and Drug Administration focuses on bugs instead of patients. You probably think “antibiotic resistance” means that a bacterial infection can’t be cured by any antibiotics.

The combination of aztreonam with avibactam aims to restore aztreonam's activity against gram-negative bacteria that are becoming increasingly resistant to antibiotics. Specifically, it targets ...

The Directorate General of Foreign Trade (DGFT), under the ministry of commerce & industry, has announced amendments to the Standard Input Output Norms (SION) for the export of erythromycin stearate ...

Antimicrobial resistance is the ability of microorganisms such as bacteria, fungi or protozoans to grow despite exposure to antimicrobial substances designed to inhibit their growth. Microbes can ...